PGY2 Oncology Pharmacy Residency
PGY2 Oncology Preceptors
The purpose of this PGY2 pharmacy residency program is to build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification.
This specialty residency is designed to provide advanced clinical training in oncology and leadership development opportunities. Upon completion of the residency, the graduates’ advanced knowledge and leadership skills will enable them to practice as an integral member of an interdisciplinary team in the care of the oncology patient, engage in clinical instructor/precepting opportunities and they will be prepared to attain board certification (BCOP).
Flexible, comprehensive training in both acute care and ambulatory oncology settings with a focus on multidisciplinary collaboration.
- Rotations and activities are tailored to meet the needs and interests of each resident.
- Year-long research projects will be ready to be submitted for publication.
- Residents will have the opportunity to precept PGY1 pharmacy residents and PharmD students on clinical rotations.
Duration/Type: 12-month residency
Number of Positions: 4
Application Deadline: Jan. 2, 2025
Starting Date: July 7, 2025
Stipend: $53,040
Requirements for Acceptance:
National Match Code: 635260
#J-18808-Ljbffr
